Back to Search
Start Over
The prognostic value of serum thyroid-stimulating hormone level post-lobectomy in low- and intermediate-risk papillary thyroid carcinoma
- Source :
- Journal of Surgical Oncology.
- Publication Year :
- 2018
- Publisher :
- Wiley, 2018.
-
Abstract
- Background This study was undertaken to determine the optimal thyroid-stimulating hormone (TSH) value associated with structural recurrence in patients with low-risk or intermediate-risk papillary thyroid carcinoma (PTC) who underwent thyroid lobectomy. Methods Patients with PTC (n = 1047) who received thyroid lobectomy and central compartment node dissection were included in the study. Results Structural recurrence occurred in 42 of the patients (4.0%), and no patient died of PTC. Multivariate analysis showed a primary tumor size (with a cut-off of 0.85 cm) and serum TSH level measured 1 year after the initial surgery (cut-off 1.85 mU/L) independently predicted structural recurrence. Conclusions TSH levels during the early postoperative period need to be monitored and maintained in the lower normal range even in patients with low- or intermediate-risk PTC undergoing thyroid lobectomy.
- Subjects :
- Male
endocrine system
medicine.medical_specialty
endocrine system diseases
Thyrotropin
030209 endocrinology & metabolism
Thyroid Lobectomy
Gastroenterology
Thyroid carcinoma
03 medical and health sciences
0302 clinical medicine
Thyroid-stimulating hormone
Risk Factors
Internal medicine
Biomarkers, Tumor
medicine
Humans
In patient
Postoperative Period
Thyroid Neoplasms
business.industry
General Medicine
Middle Aged
Prognosis
Carcinoma, Papillary
Dissection
Oncology
Lymphatic Metastasis
030220 oncology & carcinogenesis
Thyroidectomy
Female
Surgery
Thyroid stimulating hormone level
Neoplasm Recurrence, Local
business
Intermediate risk
Follow-Up Studies
Hormone
Subjects
Details
- ISSN :
- 00224790
- Database :
- OpenAIRE
- Journal :
- Journal of Surgical Oncology
- Accession number :
- edsair.doi.dedup.....4b438407d42f28b989d1f72d5e94e960